SES ESG Research Assigns 69.7 Score to Gufic Biosciences for FY'26
Gufic Biosciences Ltd 路 Others (Uncategorized) 路 13 Nov 2026, 11:59 pm
SES ESG Research Assigns 69.7 Score to Gufic Biosciences for FY'26 Gufic Biosciences received an independent overall Environmental, Social, and Governance (ESG) rating of 69.7/100 (Category: Medium) for FY'26 from SEBI-registered Category-II ESG provider SES ESG Research. Assigned via a report dated 12th Nov'26, the evaluation was conducted independently based on publicly available information without direct engagement by the company.
Original exchange filing (PDF)
More announcements from Gufic Biosciences Ltd
- Intimation of Audio Recording of Earnings Conference Call held on November 16, 2026 at 04:30 p.m. is attached herewith 路 17 Nov 2026
- Investor Presentation is attached herewith 路 15 Nov 2026
- Intimation for appointment of Additional Director (Non-Executive Independent Director) of the Company is attached herewith. 路 15 Nov 2026
- Gufic Biosciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 15 Nov 2026
- Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year Ended September 30, 2026 is attached herewith 路 15 Nov 2026
- Outcome of the Board of Directors Meeting held on Saturday, November 14, 2026 is attached herewith. 路 15 Nov 2026
- Intimation of Earnings Conference Call scheduled to be held on November 16, 2026 is attached herewith 路 16 Nov 2026
- Gufic Biosciences Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 14 Nov 2026
